GeneDx Holdings Corp.Securities class action lawsuit alleging false statements about Fabric Genomics' viability, causing stock drop and revenue guidance cut.

SueWallSt reminds investors that a securities class action has been filed against GeneDx Holdings Corp. and the lead plaintiff deadline is August 3, 2026. The lawsuit covers purchasers of WGS stock between April 16, 2025 and May 4, 2026 who lost money. The action alleges that GeneDx leadership knew about Fabric Genomics' deteriorating viability well before disclosing problems, and that positive representations about Fabric were materially false. WGS shares fell 49.20 percent, a loss of $33.42 per share, after the company disclosed a $31.2 million impairment charge tied to Fabric Genomics and cut full-year revenue guidance by approximately $65 million. Investors may contact Joseph E. Levi at SueWallSt for a free evaluation.
GeneDx Holdings Corp.Securities class action lawsuit alleging false statements about Fabric Genomics' viability, causing stock drop and revenue guidance cut.
Deteriorating viability of Fabric Genomics led to $31.2 million impairment charge for GeneDx, indicating financial trouble.